# James Richardson & Sons

> James Richardson & Sons is a VC fund in Winnipeg backing Biotechnology and Robotics. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Winnipeg, Canada
- Total investments: 5
- Last investment: Jul 2025
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.jrsl.ca

James Richardson & Sons is a VC fund in Winnipeg focused on Biotechnology and Robotics. James Richardson & Sons, Limited, established in 1857, is a private family-owned and operated Canadian corporation. Headquartered in Winnipeg, Manitoba, the Firm is involved in the international grain trade and agri-food business, energy, real estate, financial services and investment.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 40% |
| Robotics | 1 | 20% |
| Biopharma | 1 | 20% |
| Health Care | 1 | 20% |
| Therapeutics | 1 | 20% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 20% |
| Series C | 1 | 20% |
| Series D | 1 | 20% |
| Series E | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Canada | 2 | 40% |
| United States | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| 4AG Robotics | 4AG Robotics develops fully automated harvesting devices to replace manual labor in commercial mushroom farms. | $29M | Series B | Jul 29, 2025 |  |
| 4AG Robotics | 4AG Robotics develops fully automated harvesting devices to replace manual labor in commercial mushroom farms. | $12.8M | Series A | Nov 15, 2023 |  |
| Neuromed Pharmaceuticals | Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada. | $53.3M | Series E | Aug 21, 2007 |  |
| Neuromed Pharmaceuticals | Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada. | $25M | Series D | Mar 08, 2006 |  |
| Ventaira Pharmaceuticals | Ventaira Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development of new inhalation products by utilizing its novel proprietary electrohydrodynamic (EHD) aerosolization and formulation technologies. | $13.5M | Series C | Apr 05, 2005 |  |

5 of 5 investments shown.

## Co-investors
- [BDC Venture Capital](https://shizune.co/investors/profile/bdc-venture-capital) — VC Fund, 4 deals together
- [InBC Investment](https://shizune.co/investors/profile/inbc-investment) — VC Fund, 3 deals together
- [Emmertech](https://shizune.co/investors/profile/emmertech) — VC Fund, 2 deals together
- [GrowthWorks Capital](https://shizune.co/investors/profile/growthworks) — VC Fund, 2 deals together
- [MPM Capital](https://shizune.co/investors/profile/mpm-capital) — VC Fund, 2 deals together
- [RBC Capital](https://shizune.co/investors/profile/royal-bank-of-canada) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does James Richardson & Sons invest in?

James Richardson & Sons invests primarily in Biotechnology, Robotics and Biopharma startups, most often at Series B and Series C stage. Most of the 5 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did James Richardson & Sons last invest?

The most recent investment recorded for James Richardson & Sons closed in Jul 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co